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So here we are—
hoping that Con-
gress has the will to
create a new health
care system that
solves delivery
problems, but once
again gearing up to
fight physician re-
imbursement issues,
the sustained
growth revenue-
mandated cuts, and
attacks on Stark
exemptions.y original intention with this column was to comment on how this is a year of
health care reform. Below this brief commentary, which became necessary with
recent events, you will find my original column.
While we had hoped for significant reform to promote quality care, we now find ourselves
n the midst of major activity by Congress and the Obama Administration that is centered
redominantly on coverage and funding issues, possibly resulting in no delivery of real reform
r significant changes in the sustained growth revenue formula. To make matters worse, on
uly 1, the Centers for Medicare and Medicaid Services (CMS) released proposed Medicare
ayment rules that, if finalized, will include severe reductions for cardiology reimbursement. So
ere we are—hoping that Congress has the will to create a new health care system that solves
elivery problems, but once again gearing up to fight physician reimbursement issues, the sus-
ained growth revenue-mandated cuts, and attacks on Stark exemptions.
Congress’s chance to create a system that improves health care delivery, quality, and out-
omes and lowers costs took a significant blow last week with the release of the CMS proposed
edicare payment rules. Instead of working to improve quality and outcomes and long-term
ontinuity of care, the American College of Cardiology (ACC) and other similar organizations
ill have to direct their efforts at fighting the CMS proposals. By reducing cardiology reim-
ursement in general by 10% with cuts as great as 50% for echocardiography and single-
hoton emission cardiac tomography, the proposed rule effectively removes any chance that car-
iovascular professionals and other subspecialists would work with Congress on physician offsets
s “pay-fors” for reform. Congress and the Obama Administration also should consider the de-
ree to which CMS has alienated the physician community and should probably re-gauge the
illingness of physicians to work toward reform in light of these proposed rules. This new
urn also threatens to split medicine into factions competing for dollars, rather than working
n unity to improve the quality and delivery of health care for all Americans.
Suffice it to say that the ACC will do all in its power to protect our ability to provide indi-
idualized state-of-the-science quality care to our patients and to protect the viability of car-
iology practices.
Still, this is a year of health care reform, and I bear some obligation to comment on
he topic at least once in this column even though our attention needs to focus on the
ecently announced payment cuts for cardiology. Over the years, we have heard continu-
us chatter about problems with the health care system, but little has been offered in the
ay of solutions. While the chatter continued, the costs of health care continued rising,
eadlines appeared about significant differences in regional utilization unrelated to de-
ographics (1), the number of uninsured increased, and obesity, with its associated car-
iovascular risk, became rampant.
As a medical community, we offered little in the way of meaningful solutions to eitherurtail health care costs or promote preventive care, and so now Congress is trying to
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roblems while they “improve” physician reimbursement
nd find the methods for funding the added health care.
Based on recent clinical trial and registry data, cardiovas-
ular professionals have evidence suggesting that many of the
eart disease treatments we offer are not always needed to
nsure longevity and quality of life, but they do increase
osts. Recent observations have generated discussion about
he appropriate use of elective percutaneous intervention
2,3), cardiac surgery (4), and implantable cardioverter-defi-
rillators (5,6), and inappropriate use of imaging continues
o be a topic of discussion. These studies suggest that if we
sed therapies and imaging more appropriately, costs would
ecrease and we would have added funds to cover the in-
reased number of uninsured citizens. There is also a percep-
ion that improving efficiency and care delivery would im-
rove the national outcomes statistics, which presently put us
ehind most other advanced countries in health care out-
omes and put us well ahead of these countries in per capita
ost for health care (7). That perception may not be correct,
ut it holds sway in the current health care debate.
reaking Out of a Self-Perpetuating System
o, the task remains to create a system that improves
ealth care delivery, improves quality and outcomes, and
owers cost. Improving quality and outcomes involves
reater attention to long-term continuity of care of pa-
ients with chronic heart disease. For example, manage-
ent of heart failure (HF) is best done with a team ap-
roach that includes frequent communication and
urveillance, attention to small changes in health status,
nd patients’ participation in their care. This approach has
een shown to reduce hospitalizations and emergency
oom visits (8–10) and improve quality of life, but our
resent system offers no recognition of this model of care
nd provides limited reimbursement. With our perverse
ayment system, the incentive is to ignore the long-term
are of an HF patient and to manage their recurrent exac-
rbations with hospitalizations and the associated proce-
ures to treat acute decompensated HF. Insurers limit
ospital days and deny coverage for a newly insured pa-
ient with HF, so patients with HF who change employ-
rs are likely to lose their coverage. Under this system,
verybody gains except the patient. Similar care issues
pply to chronic lung disease, diabetes, hypertension, and
ven preventive cardiology. With the current reimburse-
ent system, prevention and chronic disease manage-
ent—although good for the patient—are not good eco-
omically for hospitals and physicians.
We have lived with this episodic care or sick patient reim-
ursement system long enough to consider it the norm, so
he reform needed to break out of this habit will take some
ime. The process this year in Washington is likely to be, at
est, a start, but it will not provide a complete solution. shere are many logical solutions to reforming our system;
owever, none of them will be easy to implement, and all
ill be resisted by those who stand to lose from the reforms.
f we design reform to preserve income for the current par-
icipants—insurers, hospitals, providers, lawyers, drug and
evice manufacturers—reform will be difficult to achieve.
his collective group of participants did promise President
bama that they would reduce health care costs over the
ext few years, but I do not think this translates into a plan
o reduce their incomes. So from the start, the math does
ot work. Let us set aside income and special interests for a
oment and look at what reform could be.
ealistic View of Universal Coverage
large part of the current debate on restructuring health
are revolves around providing coverage and access for the
7 million uninsured. Current proposals include creating
nsurance exchanges with payment subsidies for those in
overty and creating a government-subsidized, public in-
urance plan that would compete with private payers. Op-
osition to these plans is loud from many quarters. Insur-
rs fear that either option will be more competitive than
rivate insurance and that people will move away from
rivate insurance. They foresee that we would inevitably
rift to a totally government-run plan, which many pro-
laim as “socialized medicine.” In other countries, such
ystems have severely limited care and have driven pa-
ients to seek care abroad or in coexisting private plans.
The official position of the ACC on this issue leaves
oom for public and private insurance in a pluralistic cov-
rage structure. All of the advanced countries in the world
ave a public plan, and most also have private plans that
perate in parallel. Having a public option provides a
afety net for those in poverty, and the competition forces
rivate plans to be better social stewards. If the new sys-
em was properly constructed, Americans would have
hoices while physicians and hospitals would benefit from
n influx of fully-covered patients. Raising Medicaid pay-
ents to Medicare levels would also improve patient ac-
ess and physician reimbursement.
Clearly, a public plan has limitations and is not the sole
nswer to health care reform. However, some form of
ublic option has a place in the overall picture, possibly
hrough insurance cooperatives supported by government
rants or loans that would minimize government involve-
ent in the new health plans.
With all of the rhetorical objections to a public plan,
ew alternatives have been offered to resolve the problem
f the uninsured. I believe this has become apparent to
any of the legislators, and the argument for a public
ption has become compelling. We should soon know the
utcome of this debate. Our society has always solved
roblems brought on by change, and the addition of a
ublic plan would likely generate a number of innovative
ystems that will allow private and public insurance to
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he number of uninsured Americans.
aying for Health Instead of Sickness
he other important change that is needed is the recogni-
ion that reimbursement should be aimed at reducing
ickness, not encouraging it. To create a system that re-
ards better quality care and improves longevity is a
aunting task. We certainly do not want to wait 40 years
ntil a patient is 85 years old to show that our care ex-
ended and improved his or her quality of life. Such a
eimbursement system would require practices to exist for
everal generations to collect their proper quality reward.
What are the alternatives? The ACC proposes the use
f process measures (following guidelines, appropriate use
riteria, and performance measures), the use of electronic
ealth records, connectivity with other practices, and
-prescribing as measures of quality that should be re-
arded. Although the data are limited, studies support
hat following guidelines and performance measures im-
roves outcome and reduces mortality (11). Connectivity
hrough electronic medical records reduces redundancy in
esting and allows more timely data sharing for patient
are. Quality measures can be documented through regis-
ries, such as the National Cardiovascular Data Registry,
n area in which the ACC has been a leader in develop-
ent and implementation. With the IC3 Program, we
an report the quality of a practice based on documented
rocess measures and provide immediate feedback to
ractitioners about their practice’s performance.
The new health care system must commit to reimburs-
ng for quality performance, and it must be more than the
oken 1% to 2% offered by the Physician Quality Reim-
ursement Initiative program. The new health care system
eeds to develop formulas for integrated care of chronic
isease. These “episode of care” models are being devel-
ped, and the ACC has provided a model regarding post-
ospitalization for congestive HF to CMS for consider-
tion. Any new reimbursement systems should reward
ractices for reducing hospitalizations and stabilizing
ealth status through team care for chronic cardiac dis-
ases, such as HF, chronic stable angina, atrial fibrillation,
nd other chronic arrhythmias. Many noncardiac chronic
iseases would also benefit from this type of care. A sys-
em for rewarding practices that provide intense programs
f cardiovascular disease prevention through surveillance
f risk factors, education, early intervention with medica-
ions, and lifestyle programs should also be part of a re-
ormed reimbursement system.
edicine Has Changed
or centuries, physicians have been trained to treat dis-
ases, but this tradition comes from times when the earli-
st stages of disease and risks for disease were unknown.oday, we have the knowledge and the tools to intervene
arly in the disease process before overt symptoms of an
rreversible disorder are manifest. Our systems for care
nd reimbursement need to be focused on the treatment
f “pre-disease” and maintenance of health. This change,
hich represents a significant departure from the past,
ill provide for a healthier society and ultimately reduce
he overall cost of care. Changing the health care system
rom one that focuses on disease to one that focuses on
ealth and longevity will take time; my guess is 20 years.
his is all the more reason for us to start today to advo-
ate for a different reimbursement system, to educate the
ext generation of physicians in aiming for prevention
nd long-term engagement with their patients, and to
hift our own practice behavior toward more prevention
nd long-term care.
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